News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Report on Extraordinary General Meeting in Neurosearch A/S (NEUR.CO)



10/24/2012 8:51:37 AM

At the company's Extraordinary General Meeting today, the sale of Huntexil® to Teva Pharmaceutical Industries Ltd. through the fully owned affiliate Ivax International GmbH was approved by the general meeting.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES